126 related articles for article (PubMed ID: 15736473)
1. High-dose tamoxifen treatment increases the incidence of multifocal tumor recurrences in glioblastoma patients.
Puchner MJ; Giese A; Lohmann F; Cristante L
Anticancer Res; 2004; 24(6):4195-203. PubMed ID: 15736473
[TBL] [Abstract][Full Text] [Related]
2. Pre-irradiation chemotherapy for newly diagnosed high grade astrocytoma.
Mathieu NT; Genet D; Labrousse F; Bouillet P; Denes SL; Martin J; Labourey JL; Venat L; Clavere P; Moreau JJ
Anticancer Res; 2004; 24(2C):1249-53. PubMed ID: 15154655
[TBL] [Abstract][Full Text] [Related]
3. The influence of tamoxifen on the secretion of transforming growth factor-beta2 (TGF-beta2) in glioblastomas: in vitro and in vivo findings.
Puchner MJ; Köppen JA; Zapf S; Knabbe C; Westphal M
Anticancer Res; 2002; 22(1A):45-51. PubMed ID: 12017331
[TBL] [Abstract][Full Text] [Related]
4. [Regrowth pattern of glioblastoma multiforme after radiotherapy].
Nagashima T; Matsutani M; Nakamura O; Tanaka Y
Gan No Rinsho; 1989 Sep; 35(11):1272-6. PubMed ID: 2554006
[TBL] [Abstract][Full Text] [Related]
5. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
[TBL] [Abstract][Full Text] [Related]
6. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of high-dose chemotherapy before radiation in children with newly diagnosed high-grade astrocytoma: final analysis of Children's Cancer Group Study 9933.
MacDonald TJ; Arenson EB; Ater J; Sposto R; Bevan HE; Bruner J; Deutsch M; Kurczynski E; Luerssen T; McGuire-Cullen P; O'Brien R; Shah N; Steinbok P; Strain J; Thomson J; Holmes E; Vezina G; Yates A; Phillips P; Packer R
Cancer; 2005 Dec; 104(12):2862-71. PubMed ID: 16315242
[TBL] [Abstract][Full Text] [Related]
8. Outcome and prognostic factors in cerebellar glioblastoma multiforme in adults: a retrospective study from the Rare Cancer Network.
Weber DC; Miller RC; Villà S; Hanssens P; Baumert BG; Castadot P; Varlet P; Abacioglu U; Igdem S; Szutowicz E; Nishioka H; Hofer S; Rutz HP; Ozsahin M; Taghian A; Mirimanoff RO
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):179-86. PubMed ID: 16814953
[TBL] [Abstract][Full Text] [Related]
9. Pseudoprogression and treatment effect.
Jahangiri A; Aghi MK
Neurosurg Clin N Am; 2012 Apr; 23(2):277-87, viii-ix. PubMed ID: 22440871
[TBL] [Abstract][Full Text] [Related]
10. Do the time to chemotherapy response and the dose intensity have an impact on patient outcome in advanced non-small cell lung cancer?
Radosavljevic D; Golubicic I; Gavrilovic D; Kezic I; Jelic S
J BUON; 2009; 14(2):203-9. PubMed ID: 19650167
[TBL] [Abstract][Full Text] [Related]
11. Postoperative hypofractionated radiotherapy in glioblastoma multiforme.
Arslan M; Karadeniz AN; Aksu G; Güveli M; Fayda M; Doğan AK; Akyüz F
J BUON; 2006; 11(1):39-42. PubMed ID: 17318950
[TBL] [Abstract][Full Text] [Related]
12. A pilot safety study of lenalidomide and radiotherapy for patients with newly diagnosed glioblastoma multiforme.
Drappatz J; Wong ET; Schiff D; Kesari S; Batchelor TT; Doherty L; Lafrankie DC; Ramakrishna N; Weiss S; Smith ST; Ciampa A; Zimmerman J; Ostrowsky L; David K; Norden A; Barron L; Sceppa C; Black PM; Wen PY
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):222-7. PubMed ID: 18513880
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme.
Reardon DA; Egorin MJ; Quinn JA; Rich JN; Gururangan S; Vredenburgh JJ; Desjardins A; Sathornsumetee S; Provenzale JM; Herndon JE; Dowell JM; Badruddoja MA; McLendon RE; Lagattuta TF; Kicielinski KP; Dresemann G; Sampson JH; Friedman AH; Salvado AJ; Friedman HS
J Clin Oncol; 2005 Dec; 23(36):9359-68. PubMed ID: 16361636
[TBL] [Abstract][Full Text] [Related]
14. [Chemotherapy protocol "8 drugs in 1 day" in patients with recurrent malignant glioma].
Jeremić B; Grujicić D; Matović M
Srp Arh Celok Lek; 1994; 122(3-4):73-5. PubMed ID: 17972813
[TBL] [Abstract][Full Text] [Related]
15. Multifocal glioblastoma multiforme: prognostic factors and patterns of progression.
Showalter TN; Andrel J; Andrews DW; Curran WJ; Daskalakis C; Werner-Wasik M
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):820-4. PubMed ID: 17499453
[TBL] [Abstract][Full Text] [Related]
16. Imaging after GliaSite brachytherapy: prognostic MRI indicators of disease control and recurrence.
Kleinberg L; Yoon G; Weingart JD; Parisi M; Olivi A; Detorie NA; Chan TA
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1385-91. PubMed ID: 19394153
[TBL] [Abstract][Full Text] [Related]
17. Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma.
Chamberlain MC; Glantz MJ
Neurosurgery; 2008 Oct; 63(4):720-6; author reply 726-7. PubMed ID: 18981882
[TBL] [Abstract][Full Text] [Related]
18. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
[TBL] [Abstract][Full Text] [Related]
19. Surgery, tamoxifen, carboplatin, and radiotherapy in the treatment of newly diagnosed glioblastoma patients.
Puchner MJ; Herrmann HD; Berger J; Cristante L
J Neurooncol; 2000 Sep; 49(2):147-55. PubMed ID: 11206010
[TBL] [Abstract][Full Text] [Related]
20. Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of glioblastoma: a pilot study.
Menei P; Venier MC; Gamelin E; Saint-André JP; Hayek G; Jadaud E; Fournier D; Mercier P; Guy G; Benoit JP
Cancer; 1999 Jul; 86(2):325-30. PubMed ID: 10421269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
